Studies on carbohydratemetabolizing enzymes. 2. Trans-alpha-glucosylation by extracts of Tetrahymena pyriformis.

A. Archibald,D. Manners

IF: 3.766

Biochemical Journal

Abstract:

What problem does this paper attempt to address?

The emerging roles of exosomes in autoimmune diseases, with special emphasis on microRNAs in exosomes

Chenggui Miao,Xiao Wang,Wanwan Zhou,Jinling Huang

DOI: https://doi.org/10.1016/j.phrs.2021.105680

IF: 10.334

2021-07-01

Pharmacological Research

Abstract:<p>Autoimmune diseases include rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), systemic vasculitis, dermatomyositis, systemic sclerosis (SSc), mixed connective tissue disease, autoimmune hemolytic anemia, autoimmune thyroiditis (AITD) and ulcerative colitis. Exosomes exist in body fluids, including blood, saliva, urine, cerebrospinal fluid and milk. They are mainly derived from the invagination of intracellular lysosomal particles, which are released into the extracellular matrix after fusion of the outer membrane of the exosomes with the cell membrane. Exosomes mediate intercellular communication and regulate the biological activity of receptor cells by carrying proteins, nucleic acids and lipids. Evidences show that exosomes are involved in the pathogenesis of various autoimmune diseases. In view of the important roles of exosomes in autoimmune diseases, this work systematically reviewed the effects of exosomes on the pathogenesis of autoimmune diseases, especially the regulatory roles of exosome derived microRNAs (miRNAs) in the pathogenesis of RA, SLE, dermatomyositis, SSc, AITD and ulcerative colitis. The review of the roles of exosomes in autoimmune diseases will help to clarify the pathogenesis of these diseases and explore new diagnostic markers and therapeutic targets.</p>

pharmacology & pharmacy
Exosomes as biomarkers and therapeutic delivery for autoimmune diseases: Opportunities and challenges

Yang Fang,Jing Ni,Yun-Sheng Wang,Yan Zhao,Ling-Qiong Jiang,Cong Chen,Ruo-Di Zhang,Xi Fang,Peng Wang,Hai-Feng Pan

DOI: https://doi.org/10.1016/j.autrev.2022.103260

IF: 17.39

2022-12-23

Autoimmunity Reviews

Abstract:Exosomes are spherical lipid bilayer vesicles composed of lipids, proteins and nucleic acids that deliver signaling molecules through a vesicular transport system to regulate the function and morphology of target cells, thereby involving in a variety of biological processes, such as cell apoptosis or proliferation, and cytokine production. In the past decades, there are emerging evidence that exosomes play pivotal roles in the pathological mechanisms of several autoimmune diseases (ADs), including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), type 1 diabetes mellitus (T1DM), Sjogren's syndrome (SS), multiple sclerosis (MS), inflammatory bowel disease (IBD). systemic sclerosis (SSc), etc . Several publications have shown that exosomes are involved in the pathogenesis of ADs mainly through intercellular communication and by influencing the response of immune cells. The level of exosomes and the expression of nucleic acids can reflect the degree of disease progression and are excellent biomarkers for ADs. In addition, exosomes have the potential to be used as drug carriers thanks to their biocompatibility and stability. In this review, we briefly summarized the current researches regarding the biological functions of exosomes in ADs, and provided an insight into the potential of exosomes as biomarkers and therapeutic delivery for these diseases.

immunology
Exosome Content–Mediated Signaling Pathways in Multiple Sclerosis

Mina Mohammadinasr,Soheila Montazersaheb,Hormoz Ayromlou,Vahid Hosseini,Ommoleila Molavi,Mohammad Saeid Hejazi

DOI: https://doi.org/10.1007/s12035-023-03862-2

IF: 5.682

2024-01-10

Molecular Neurobiology

Abstract:Exosomes are small extracellular vesicles with a complex lipid-bilayer surface and 30–150 nm diameter. These vesicles play a critical role in intercellular signaling networks during physiopathological processes through data trafficking and cell reprogramming. It has been demonstrated that exosomes are involved in a variety of central nervous system (CNS) disorders such as multiple sclerosis (MS). Exosome mediators' cell-to-cell communication is possibly by delivering their contents such as proteins, RNAs (coding and non-coding), DNAs (mitochondrial and genomic), and transposable elements to the target cells. Exosomal microRNAs (miRNAs) differ in their expression patterns in MS disease, thereby providing novel diagnostic and prognostic biomarkers and therapeutic options for better treatment of MS disease. Furthermore, these microvesicles are non-immunogenic and non-toxic therapeutic tools for transferring miRNAs across the blood-brain barrier (BBB). Collectively, exosomes could be used as novel drug delivery devices for the treatment of MS patients. This review summarized research regarding the exosomes from serum, plasma, PBMC, and other cells in MS patients and experimental models. We also provide a critical view of exosome content-mediated signaling pathways in MS, including TNF-α, TGF-β, NF-κB, and Wnt pathways. The use of exosomes as a therapeutic potential in MS has also been discussed.

neurosciences
Exosomes in Action: Unraveling Their Role in Autoimmune Diseases and Exploring Potential Therapeutic Applications

Shuanglong Zhou,Jialing Huang,Yi Zhang,Hongsong Yu,Xin Wang

DOI: https://doi.org/10.4110/in.2024.24.e12

2024-01-01

Immune Network

Abstract:Exosomes are double phospholipid membrane vesicles that are synthesized and secreted by a variety of cells, including T cells, B cells, dendritic cells, immune cells, are extracellular vesicles. Recent studies have revealed that exosomes can play a significant role in under both physiological and pathological conditions. They have been implicated in regulation of inflammatory responses, immune response, angiogenesis, tissue repair, and antioxidant activities, particularly in modulating immunity in autoimmune diseases (AIDs). Moreover, variations in the expression of exosome-related substances, such as miRNA and proteins, may not only offer valuable perspectives for the early warning, and prognostic assessment of various AIDs, but may also serve as novel markers for disease diagnosis. This article examines the impact of exosomes on the development of AIDs and explores their potential for therapeutic application.

immunology
The Role of MicroRNAs in Autoimmune Diseases with Skin Involvement

X. Deng,Y. Su,H. Wu,R. Wu,P. Zhang,Y. Dai,T.‐M. Chan,M. Zhao,Q. Lu,T.-M. Chan

DOI: https://doi.org/10.1111/sji.12261

2015-02-24

Scandinavian Journal of Immunology

Abstract:MicroRNAs (miRNAs) are small non-coding RNA molecules that negatively modulate gene expression by binding to the 3' untranslated region (UTR) of target messenger RNAs (mRNAs), which leads to the degradation or translational repression of their target mRNAs. Previous research on miRNAs has revealed a new paradigm of gene regulations and pathways involved in the pathogenesis of autoimmune disorders and malignant diseases. The roles of miRNAs in cellular processes, including cell differentiation, proliferation, apoptosis and immune functions, are not clearly understood. MiRNAs are easily detected in a variety of sources, including tissues, serum and other body fluids, and this make them a good biological sample for pathogenic studies and disease biomarker development. This review encompasses the current understanding of the roles of miRNAs in autoimmunity and the cellular and molecular mechanisms of miRNAs in various autoimmune diseases (AIMDs). Specifically, we focus on the target genes of miRNAs and the biological processes associated with autoimmune diseases with skin involvement, including systemic lupus erythematosus, psoriasis, systemic sclerosis, Behcet's disease and dermatomyositis. In addition, the diagnostic and therapeutic relevance of miRNAs that are involved in autoimmunity are elucidated to provide information for clinical implications.

immunology
Potential therapeutic and diagnostic approaches of exosomes in multiple sclerosis pathophysiology

Nima Hasaniani,Sina Nouri,Moein Shirzad,Sahar Rostami-Mansoor

DOI: https://doi.org/10.1016/j.lfs.2024.122668

IF: 6.78

2024-04-26

Life Sciences

Abstract:Exosomes are bilayer lipid vesicles that are released by cells and contain proteins, nucleic acids, and lipids. They can be internalized by other cells, inducing inflammatory responses and instigating toxicities in the recipient cells. Exosomes can also serve as therapeutic vehicles by transporting protective cargo to maintain homeostasis. Multiple studies have shown that exosomes can initiate and participate in the regulation of neuroinflammation, improve neurogenesis, and are closely related to the pathogenesis of central nervous system (CNS) diseases, including multiple sclerosis (MS). Exosomes can be secreted by both neurons and glial cells in the CNS, and their contents change with disease occurrence. Due to their ability to penetrate the blood-brain barrier and their stability in peripheral fluids, exosomes are attractive biomarkers of CNS diseases. In recent years, exosomes have emerged as potential therapeutic agents for CNS diseases, including MS. However, the molecular pathways in the pathogenesis of MS are still unknown, and further research is needed to fully understand the role of exosomes in the occurrence or improvement of MS disease. Thereby, in this review, we intend to provide a more complete understanding of the pathways in which exosomes are involved and affect the occurrence or improvement of MS disease.

pharmacology & pharmacy,medicine, research & experimental
Differential diagnosis of trabectedin extravasation: A case report

Kosuke Yoshimi,J. Wasa,Masaki Otsuka,S. Yoshikawa,H. Goto,T. Omodaka,H. Katagiri,H. Murata,S. Hosaka,Y. Kiyohara

DOI: https://doi.org/10.1111/1346-8138.13854

2017-08-01

Abstract:Dear Editor, Trabectedin is an alkylating antitumor agent. Studies have reported that trabectedin causes serious tissue injury. However, there is no report of the utility of skin biopsies in the diagnosis of trabectedin extravasation. A 51-year-old man with multiple metastases from a malignant solitary fibrous tumor of the thigh received trabectedin. A central venous port (CVP) was implanted in the left subclavian subcutaneous fat the day before chemotherapy. We noticed that the patient’s clothes were wet 18 h after administration; however, redness, swelling and pain were not noted. Therefore, the needle was reinserted and trabectedin administration was continued. The patient developed redness around the CVP and visited the emergency room 4 days after chemotherapy (Fig. 1a). Hematological examination showed slight inflammation. We suspected CVP infection or trabectedin extravasation. We removed the CVP and administrated cefazolin for an infection. However, redness, swelling and pain persisted. We performed a skin biopsy from erythema 9 days after chemotherapy. The histopathological findings showed alteration of collagen fibers and fat necrosis without an inflammatory infiltrate (Fig. 1b,c). The wound, blood, biopsy and
Interaction of cardiac troponin with cardiotonic drugs: a structural perspective.

Monica X. Li,I. M. Robertson,B. Sykes

DOI: https://doi.org/10.1016/J.BBRC.2007.12.108

2008-04-25

Abstract:
Therapeutic potential of exosomes derived from mesenchymal stem cells for treatment of systemic lupus erythematosus

Shima Famil Samavati,Reza Yarani,Sara Kiani,Zohreh HoseinKhani,Masomeh Mehrabi,Steven Levitte,Rosita Primavera,Shashank Chetty,Avnesh S. Thakor,Kamran Mansouri

DOI: https://doi.org/10.1186/s12950-024-00381-2

2024-06-14

Journal of Inflammation

Abstract:Autoimmune diseases are caused by an imbalance in the immune system, producing autoantibodies that cause inflammation leading to tissue damage and organ dysfunction. Systemic Lupus Erythematosus (SLE) is one of the most common autoimmune diseases and a major contributor to patient morbidity and mortality. Although many drugs manage the disease, curative therapy remains elusive, and current treatment regimens have substantial side effects. Recently, the therapeutic potential of exosomes has been extensively studied, and novel evidence has been demonstrated. A direct relationship between exosome contents and their ability to regulate the immune system, inflammation, and angiogenesis. The unique properties of extracellular vesicles, such as biomolecule transportation, biodegradability, and stability, make exosomes a promising treatment candidate for autoimmune diseases, particularly SLE. This review summarizes the structural features of exosomes, the isolation/purification/quantification method, their origin, effect, immune regulation, a critical consideration for selecting an appropriate source, and their therapeutic mechanisms in SLE.

immunology
MicroRNAs and Autoimmune-Mediated Eye Diseases

Yankai Wei,Na Li,Lu Zhao,Chao Yang,Binyun Ma,Xiaorong Li,Ruihua Wei,Hong Nian

DOI: https://doi.org/10.3389/fcell.2020.00818

IF: 5.5

2020-08-20

Frontiers in Cell and Developmental Biology

Abstract:MicroRNAs (miRNAs) are evolutionarily conserved short non-coding RNAs that act at post-transcriptional regulation of gene expression by destroying target messenger RNA or inhibiting its translation. Recently, miRNAs have been identified as important regulators in autoimmunity. Aberrant expression and function of miRNAs can lead to dysfunction of immune system and mediate autoimmune disorders. Here, we summarize the roles of miRNAs that have been implicated in three representative ocular autoimmune disorders, including autoimmune uveitis, Grave's ophthalmopathy, and Sjögren's syndrome dry eye, and discuss the potential of miRNAs as biomarkers and therapeutic targets for the diagnosis and treatment of these diseases.

cell biology,developmental biology
Therapeutic prospects of MicroRNAs carried by mesenchymal stem cells-derived extracellular vesicles in autoimmune diseases

Huan Liu,Yuehong Chen,Geng Yin,Qibing Xie

DOI: https://doi.org/10.1016/j.lfs.2021.119458

IF: 6.78

2021-07-01

Life Sciences

Abstract:<p>Autoimmune diseases (ADs) are a class of chronic disease conditions with impaired tolerance to autoantigens. Currently, there is no effective treatment for ADs, and the existing medications have limitations due to non-specific targets and side effects. Accumulating evidence has shown that mesenchymal stem cells (MSCs) play a role in ADs treatment. These beneficial effects mainly rely on cell-to-cell communication through the secretion of extracellular vesicles (EVs) and soluble factors. MSC-derived EVs (MSC-EVs) could modulate adjacent and distinct cells by transferring various DNA, mRNA, non-coding RNAs, proteins, and lipids from parent cells to recipient cells. MicroRNAs (miRNAs) are small non-coding RNAs that negatively regulate multiple target genes at the post-transcriptional level and are involved in chronic inflammatory and immune processes. Compared to fluid, MSC-EVs delivery can protect miRNAs from the degradation of ribonucleases, ensuring that miRNAs are able to perform their respective crucial roles in AD recipient cells. In this review, we discussed the therapeutic prospects and challenges of miRNAs secreted by MSC-EVs (MSC-EV-miRNAs) by reviewing the experimentally verified therapeutic outcomes of MSC-EV-miRNAs for several ADs, including rheumatoid arthritis (RA), autoimmune hepatitis (AIH), asthma, colitis, systemic sclerosis (SSc) and graft-versus-host disease (GVHD).</p>

pharmacology & pharmacy,medicine, research & experimental
Exosomal Non-coding RNA Derived from Mesenchymal Stem Cells (MSCs) in Autoimmune Diseases Progression and Therapy; an Updated Review

Shireen Hamid Farhan,Saade Abdalkareem Jasim,Pooja Bansal,Harpreet Kaur,Mohammed Abed Jawad,Maytham T. Qasim,Abeer Mhussan Jabbar,Mahamedha Deorari,Ahmed Alawadi,Ali Hadi

DOI: https://doi.org/10.1007/s12013-024-01432-4

2024-09-04

Cell Biochemistry and Biophysics

Abstract:Inflammation and autoimmune diseases (AD) are common outcomes of an overactive immune system. Inflammation occurs due to the immune system reacting to damaging stimuli. Exosomes are being recognized as an advanced therapeutic approach for addressing an overactive immune system, positioning them as a promising option for treating AD. Mesenchymal stem cells (MSCs) release exosomes that have strong immunomodulatory effects, influenced by their cell of origin. MSCs-exosomes, being a cell-free therapy, exhibit less toxicity and provoke a diminished immune response compared to cell-based therapies. Exosomal non-coding RNAs (ncRNA), particularly microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) are intricately linked to various biological and functional aspects of human health. Exosomal ncRNAs can lead to tissue malfunction, aging, and illnesses when they experience tissue-specific alterations as a result of various internal or external problems. In this study, we will examine current trends in exosomal ncRNA researches regarding AD. Then, therapeutic uses of MSCs-exosomal ncRNA will be outlined, with a particle focus on the underlying molecular mechanisms.

cell biology,biochemistry & molecular biology,biophysics
The potential use of mesenchymal stem cells-derived exosomes as microRNAs delivery systems in different diseases

Elham Oveili,Somayeh Vafaei,Haniyeh Bazavar,Yeganeh Eslami,Ehsan Mamaghanizadeh,Saman Yasamineh,Omid Gholizadeh

DOI: https://doi.org/10.1186/s12964-022-01017-9

IF: 7.525

2023-01-24

Cell Communication and Signaling

Abstract:MicroRNAs (miRNAs) are a group of small non-coding RNAs that regulate gene expression by targeting mRNA. Moreover, it has been shown that miRNAs expression are changed in various diseases, such as cancers, autoimmune disease, infectious diseases, and neurodegenerative Diseases. The suppression of miRNA function can be easily attained by utilizing of anti-miRNAs. In contrast, an enhancement in miRNA function can be achieved through the utilization of modified miRNA mimetics. The discovery of appropriate miRNA carriers in the body has become an interesting subject for investigators. Exosomes (EXOs) therapeutic efficiency and safety for transferring different cellular biological components to the recipient cell have attracted significant attention for their capability as miRNA carriers. Mesenchymal stem cells (MSCs) are recognized to generate a wide range of EXOs (MSC-EXOs), showing that MSCs may be effective for EXO generation in a clinically appropriate measure as compared to other cell origins. MSC-EXOs have been widely investigated because of their immune attributes, tumor-homing attributes, and flexible characteristics. In this article, we summarized the features of miRNAs and MSC-EXOs, including production, purification, and miRNA loading methods of MSC-EXOs, and the modification of MSC-EXOs for targeted miRNA delivery in various diseases.

cell biology
Role of exosome-associated microRNA in diagnostic and therapeutic applications to metabolic disorders

Zhen-yu Yao,Wen-bin Chen,Shan-shan Shao,Shi-zhan Ma,Chong-bo Yang,Meng-zhu Li,Jia-jun Zhao,Ling Gao

DOI: https://doi.org/10.1631/jzus.b1600490

2018-03-01

Journal of Zhejiang University SCIENCE B

Abstract:Metabolic disorders are classified clinically as a complex and varied group of diseases including metabolic syndrome, obesity, and diabetes mellitus. Fat toxicity, chronic inflammation, and oxidative stress, which may change cellular functions, are considered to play an essential role in the pathogenetic progress of metabolic disorders. Recent studies have found that cells secrete nanoscale vesicles containing proteins, lipids, nucleic acids, and membrane receptors, which mediate signal transduction and material transport to neighboring and distant cells. Exosomes, one type of such vesicles, are reported to participate in multiple pathological processes including tumor metastasis, atherosclerosis, chronic inflammation, and insulin resistance. Research on exosomes has focused mainly on the proteins they contain, but recently the function of exosome-associated microRNA has drawn a lot of attention. Exosomeassociated microRNAs regulate the physiological function and pathological processes of metabolic disorders. They may also be useful as novel diagnostics and therapeutics given their special features of non-immunogenicity and quick extraction. In this paper, we summarize the structure, content, and functions of exosomes and the potential diagnostic and therapeutic applications of exosome-associated microRNAs in the treatment of metabolic disorders.
The developing role of extracellular vesicles in autoimmune diseases: special attention to mesenchymal stem cell-derived extracellular vesicles

Geovanny Genaro Reivan Ortiz,Neelam Hazoor Zaidi,Ravinder S Saini,Andres Alexis Ramirez Coronel,Tahani Alsandook,Methaq Hadi Lafta,José Luis Arias-Gonzáles,Ali H Amin,Renato R Maaliw Iii

DOI: https://doi.org/10.1016/j.intimp.2023.110531

Abstract:Autoimmune diseases are complex, chronic inflammatory conditions initiated by the loss of immunological tolerance to self-antigens. Nowadays, there is no effective and useful therapy for autoimmune diseases, and the existing medications have some limitations due to their nonspecific targets and side effects. During the last few decades, it has been established that mesenchymal stem cells (MSCs) have immunomodulatory functions. It is proposed that MSCs can exert an important therapeutic effect on autoimmune disorders. In parallel with these findings, several investigations have shown that MSCs alleviate autoimmune diseases. Intriguingly, the results of studies have demonstrated that the effective roles of MSCs in autoimmune diseases do not depend on direct intercellular communication but on their ability to release a wide spectrum of paracrine mediators such as growth factors, cytokines and extracellular vehicles (EVs). EVs that range from 50 to 5,000 nm were produced by almost any cell type, and these nanoparticles participate in homeostasis and intercellular communication via the transfer of a broad range of biomolecules such as modulatory proteins, nucleic acids (DNA and RNA), lipids, cytokines, and metabolites. EVs derived from MSCs display the exact properties of MSCs and can be safer and more beneficial than their parent cells. In this review, we will discuss the features of MSCs and their EVs, EVs biogenesis, and their cargos, and then we will highlight the existing discoveries on the impacts of EVs from MSCs on autoimmune diseases such as multiple sclerosis, arthritis rheumatic, inflammatory bowel disease, Type 1 diabetes mellitus, systemic lupus erythematosus, autoimmune liver diseases, Sjögren syndrome, and osteoarthritis, suggesting a potential alternative for autoimmune conditions therapy.
Cytokine Targeting by miRNAs in Autoimmune Diseases

Valentina Salvi,Veronica Gianello,Laura Tiberio,Silvano Sozzani,Daniela Bosisio

DOI: https://doi.org/10.3389/fimmu.2019.00015

IF: 7.3

2019-01-29

Frontiers in Immunology

Abstract:Persistent and excessive cytokine production is a hallmark of autoimmune diseases and may play a role in disease pathogenesis and amplification. Therefore, cytokine neutralization is a useful therapeutic strategy to treat immune-mediated conditions. MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate gene expression in diverse biological processes. Altered miRNA levels are observed in most autoimmune diseases and are recognized to influence autoimmunity through different mechanisms. Here, we review the impact of altered miRNA levels on the expression of cytokines that play a relevant pathogenic role in autoimmunity, namely primary pro-inflammatory cytokines, the IL-17/IL-23 axis, type I interferons and IL-10. Regulation can be either "direct" on the target cytokine, or "indirect," meaning that one given miRNA post-transcriptionally regulates the expression of a protein that in turn influences the level of the cytokine. In addition, miRNAs associated with extracellular vesicles can regulate cytokine production in neighboring cells, either post-transcriptionally or via the stimulation of innate immune RNA-sensors, such as Toll-like receptors. Because of their tremendous potential as physiological and pathological regulators, miRNAs are in the limelight as promising future biopharmaceuticals. Thus, these studies may lead in the near future to the design and testing of therapeutic miRNAs as next generation drugs to target pathogenic cytokines in autoimmunity.

immunology
The role of exosomal microRNAs in central nervous system diseases

Yifei Yu,Kun Hou,Tong Ji,Xishu Wang,Yining Liu,Yangyang Zheng,Jinying Xu,Yi Hou,Guangfan Chi

DOI: https://doi.org/10.1007/s11010-021-04053-0

IF: 3.842

2021-01-29

Molecular and Cellular Biochemistry

Abstract:MicroRNAs (miRNA), endogenous non-coding RNAs approximately 22 nucleotides long, regulate gene expression by mediating translational inhibition or mRNA degradation. Exosomes are a tool for intercellular transmission of information in which miRNA exchange plays an important role. Under pathophysiological conditions in the central nervous system (CNS), cellular transmission of exosomal miRNAs can regulate signaling pathways. Exosomal miRNAs are involved in the occurrence and development of diverse CNS diseases, such as traumatic brain injury, spinal cord injury, stroke, neurodegenerative diseases, epilepsy, and glioma. The use of exosomes as transport vehicles for certain miRNAs provides a novel therapeutic strategy for CNS diseases. Furthermore, the exosomes in body fluids change with the occurrence of diseases, indicating that subtle changes in physiological and pathological processes in vivo could be recognized by analyzing exosomes. Exosomal analysis is expected to act as a novel tool for diagnosis and prediction of neurological diseases. In this review, we present the current understanding of the implications of miRNAs in CNS diseases and summarize the role and mechanism of action of exosomal miRNA in nervous system disease models.

cell biology
Exosomes as Rheumatoid Arthritis Diagnostic Biomarkers and Therapeutic Agents

Romina Heydari,Fatemeh Koohi,Milad Rasouli,Kimia Rezaei,Elham Abbasgholinejad,Sander Bekeschus,Mohammad Doroudian

DOI: https://doi.org/10.3390/vaccines11030687

2023-03-18

Vaccines

Abstract:Rheumatoid arthritis (RA) is a chronic inflammatory joint disorder that causes systemic inflammation, autoimmunity, and joint abnormalities that result in permanent disability. Exosomes are nanosized extracellular particles found in mammals (40–100 nm). They are a transporter of lipids, proteins, and genetic material involved in mammalian cell–cell signaling, biological processes, and cell signaling. Exosomes have been identified as playing a role in rheumatoid arthritis-related joint inflammation (RA). Uniquely functioning extracellular vesicles (EVs) are responsible for the transport of autoantigens and mediators between distant cells. In addition, paracrine factors, such as exosomes, modulate the immunomodulatory function of mesenchymal stem cells (MSCs). In addition to transporting genetic information, exosomes convey miRNAs between cells and have been studied as drug delivery vehicles. In animal models, it has been observed that MSCs secrete EVs with immunomodulatory properties, and promising results have been observed in this area. By understanding the diversity of exosomal contents and their corresponding targets, it may be possible to diagnose autoimmune diseases. Exosomes can be employed as diagnostic biomarkers for immunological disorders. We here discuss the most recent findings regarding the diagnostic, prognostic, and therapeutic potential of these nanoparticles in rheumatoid arthritis and provide an overview of the evidence pertaining to the biology of exosomes in RA.

immunology,medicine, research & experimental
Potential roles of extracellular vesicles in the pathophysiology, diagnosis, and treatment of autoimmune diseases

Jing Tian,Giacomo Casella,Yuan Zhang,Abdolmohamad Rostami,Xing Li

DOI: https://doi.org/10.7150/ijbs.39629

2020-01-01

International Journal of Biological Sciences

Abstract:Since extracellular vesicles (EVs) were discovered in 1983 in sheep reticulocytes samples, they have gradually attracted scientific attention and become a topic of great interest in the life sciences field. EVs are small membrane particles, released by virtually every cell that carries a variety of functional molecules. Their main function is to deliver messages to the surrounding area in both physiological and pathological conditions. Initially, they were thought to be either cell debris, signs of cell death, or unspecific structures. However, accumulating evidence support a theory that EVs are a universal mechanism of communication. Thanks to their biological characteristics and functions, EVs are likely to represent a promising strategy for obtaining pathogen information, identifying therapeutic targets and selecting specific biomarkers for a variety of diseases, such as autoimmune diseases.In this review, we provide a brief overview of recent progress in the study of the biology and functions of EVs. We also discuss their roles in diagnosis and therapy, with particular emphasis on autoimmune diseases.

biochemistry & molecular biology
Role of Extracellular Vesicles in Autoimmune Pathogenesis

Wen-Cheng Wu,Sheng-Jiao Song,Yuan Zhang,Xing Li

DOI: https://doi.org/10.3389/fimmu.2020.579043

IF: 7.3

2020-09-23

Frontiers in Immunology

Abstract:Autoimmune diseases are conditions that emerge from abnormal immune responses to natural parts of the body. Extracellular vesicles (EVs) are membranous structures found in almost all types of cells. Because EVs often transport "cargo" between cells, their ability to crosstalk may be an important communication pathway within the body. The pathophysiological role of EVs is increasingly recognized in autoimmune diseases, including multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, Sjogren's syndrome, Type 1 diabetes, and autoimmune thyroid disease. EVs are considered as biomarkers of these diseases. This article outlines existing knowledge on the biogenesis of EVs, their role as messegers in cellular communication and the function in T/B cell differentiation and maturation, and focusing on their potential application in autoimmune diseases.

immunology

Studies on carbohydratemetabolizing enzymes. 2. Trans-alpha-glucosylation by extracts of Tetrahymena pyriformis.

The emerging roles of exosomes in autoimmune diseases, with special emphasis on microRNAs in exosomes

Exosomes as biomarkers and therapeutic delivery for autoimmune diseases: Opportunities and challenges

Exosome Content–Mediated Signaling Pathways in Multiple Sclerosis

Exosomes in Action: Unraveling Their Role in Autoimmune Diseases and Exploring Potential Therapeutic Applications

The Role of MicroRNAs in Autoimmune Diseases with Skin Involvement

Potential therapeutic and diagnostic approaches of exosomes in multiple sclerosis pathophysiology

Differential diagnosis of trabectedin extravasation: A case report

Interaction of cardiac troponin with cardiotonic drugs: a structural perspective.

Therapeutic potential of exosomes derived from mesenchymal stem cells for treatment of systemic lupus erythematosus

MicroRNAs and Autoimmune-Mediated Eye Diseases

Therapeutic prospects of MicroRNAs carried by mesenchymal stem cells-derived extracellular vesicles in autoimmune diseases

Exosomal Non-coding RNA Derived from Mesenchymal Stem Cells (MSCs) in Autoimmune Diseases Progression and Therapy; an Updated Review

The potential use of mesenchymal stem cells-derived exosomes as microRNAs delivery systems in different diseases

Role of exosome-associated microRNA in diagnostic and therapeutic applications to metabolic disorders

The developing role of extracellular vesicles in autoimmune diseases: special attention to mesenchymal stem cell-derived extracellular vesicles

Cytokine Targeting by miRNAs in Autoimmune Diseases

The role of exosomal microRNAs in central nervous system diseases

Exosomes as Rheumatoid Arthritis Diagnostic Biomarkers and Therapeutic Agents

Potential roles of extracellular vesicles in the pathophysiology, diagnosis, and treatment of autoimmune diseases

Role of Extracellular Vesicles in Autoimmune Pathogenesis